Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network
Frontiers in Physiology · 14.07.2026 · 17
DOI: 10.3389/fphys.2026.1846390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 14.07.2026. Verfasst von Nathan J Hellyer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine & Rehabilitation, Mayo Clinic, Rochester, MN, United States. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The nerve-derived growth factor neuregulin (NRG) plays a role in the regulation of skeletal muscle mass through Akt and mTOR signaling transduction pathways that regulate both protein synthesis and degradation. We previously reported that NRG increases muscle protein synthesis (~20%) in a PI3 kinase (PI3K)/Akt-dependent manner. However, the effects of NRG on protein degradation are still poorly understood and are needed to elucidate the role of NRG in the maintenance of skeletal muscle protein balance.
Methods
Neonatal diaphragm muscle ex vivo preparations were pharmacologically treated with NRG and pharmacological inhibitors of PI3K (LY294002, 50 μM), MEK (PD98059, 50 μM) or mTOR (rapamycin, 100 nM). Tyrosine release from muscle was used as a surrogate measure of protein degradation.
Results
We report that basal protein degradation in the neonatal rat diaphragm muscle is significantly reduced by NRG treatment (19%). Basal protein degradation was increased following treatment with inhibitors of PI3K, MEK or mTOR, with inhibition of each pathway sufficient to increase basal protein degradation greater than 30%. Importantly, NRG treatment in the presence of each of these inhibitors blunts the increase in protein degradation induced by inhibition of PI3K, MEK or mTOR. NRG effects were significantly blunted by rapamycin (p < 0.05 compared to NRG alone), but not by LY294002 or PD98059.
Discussion
We suggest that both the PI3K/Akt and MAP kinase pathways are important for NRG effects on protein degradation, but that mTOR may be a critical modulator of these effects and thus of protein balance in skeletal muscle.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Medicine & Rehabilitation, Mayo Clinic, Rochester, MN, United States.
- Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
Zitieren
APA
Hellyer, N. J., Gransee, H. M., Sieck, G. C., & Mantilla, C. B. (2026). Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1846390
Vancouver
Hellyer NJ, Gransee HM, Sieck GC, Mantilla CB. Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1846390
BibTeX
@article{Hellyer2026,
author = {Hellyer, Nathan J and Gransee, Heather M and Sieck, Gary C and Mantilla, Carlos B},
title = {Neuregulin attenuates diaphragm muscle protein degradation via an intricate signaling network},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1846390}
}
EUVIMED